SOLACI-SOCIME 2022 – Live Cases from Centro Médico Nacional: 20 de Noviembre, Mexico City

✔️ SOLACI-SOCIME 2022 – Live Cases from Centro Médico Nacional: 20 de Noviembre, Mexico City

✔️ SOLACI-SOCIME 2022 Scientific Session


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

LIVE CASE “VitaFlow” FROM “SANATORIO FINOCHIETTO” BA, ARGENTINA – SOLACI-SOCIME 2022

✔️ LIVE CASE “VitaFlow” FROM “SANATORIO FINOCHIETTO” BA, ARGENTINA - SOLACI-SOCIME 2022 ✔️ Video del SOLACI-SOCIME 2022

LIVE CASE “Pulmonar Valve” from Hospital Universitario Austral, BA, Argentina – SOLACI-SOCIME 2022

✔️ LIVE CASE “Pulmonar Valve” from “Hospital Universitario Austral, BA, Argentina - SOLACI-SOCIME 2022. Structural Room. ✔️ SOLACI-SOCIME 2022 Scientific Session.

SOLACI-SOCIME 2022: Live Cases from Centro Médico Nacional Siglo XXI, Mexico City

✔️ SOLACI-SOCIME 2022: Live Cases from Centro Médico Nacional Siglo XXI, Mexico City. ✔️ SOLACI-SOCIME 2022 Scientific Session. 

SOLACI-SOCIME 2022 – Live Cases from Centro Médico Nacional: La Raza, Mexico City

✔️ Live Cases from Centro Médico Nacional: La Raza, Mexico City ✔️ Sponsored cases by Orbus & Terumo ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨‍🏫 Contents: 00:15 -...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...